BiomX Inc. Skyrocketed
Fri, Dec 16, 2022 at 07:03 PM
BiomX Inc. (PHGE:NYSEMKT) soared at $0.22, a gain of 63.6%. On Fri, Dec 16, 2022, PHGE:NYSEMKT touched a New 2-Week Intraday High of $0.26. The stock appeared on our News Catalysts scanner on Tue, Nov 29, 2022 at 10:36 AM in the 'MISCELLANEOUS' category. From Fri, Dec 02, 2022, the stock recorded 10.00% Up Days and 18.18% Green Days
About BiomX Inc. (PHGE:NYSEMKT)
BiomX Inc is a clinical stage microbiome company based in Israel. The company is engaged on developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectalcancer, and primary sclerosing cholangitis.
Top 10 Gainers:
- Renovare Environmental Inc. (RENO:NASDAQ), 900%
- Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
- Maxar Technologies Inc. (MAXR:NYSE), 124.81%
- NantHealth, Inc. (NH:NASDAQ), 98.95%
- TiGenix NV (TIG:NASDAQ), 91.51%
- Invacare Corporation (IVC:NYSE), 66.69%
- BiomX Inc. (PHGE:NYSEMKT), 63.56%
- Excellon Resources Inc. (EXN:NYSEMKT), 56.63%
- BeyondSpring Inc. (BYSI:NASDAQ), 49.02%
- Meihua International Medical Technologies Co. Ltd. (MHUA:NASDAQ), 38.82%